Drug
Kx2 361
Kx2 361: highest development phase Phase 1, developed by Athenex. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Athenex
Trials
| Drug | Phase | Indication |
|---|---|---|
| KX2-361 NCT02326441 | Phase 1 | Advance Malignancies |
Latest
No recent events.
Follow Kx2 361 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.